Daniel Tillett, Chief Executive Officer & Managing Director at Race Oncology Ltd., holds 17.76M shares in Race Oncology Ltd. (Ticker: AU:RAC), holds 44.19M shares in Simble Solutions Ltd. (Ticker: AU:SIS), holds 62.00M shares in Tryptamine Therapeutics (Ticker: AU:ENP). Most recently, Daniel Tillett Bought ― shares of Race Oncology Ltd. on Nov 28, 2025 for an estimated value of AU$58.74K.
What is the percentage of profitable transactions made by Daniel Tillett?
The percentage of profitable transactions made by Daniel Tillett is 29%.
What is the average return per transaction made by Daniel Tillett?
The average return per transaction made by Daniel Tillett is 133.20%.
What stocks does Daniel Tillett hold?
Daniel Tillett holds: AU:RAC, AU:SIS, AU:ENP stocks.
What was Daniel Tillett’s latest transaction?
Daniel Tillett latest transaction was an Informative Buy of AU$58.74K.
What was Daniel Tillett's most profitable transaction?
Daniel Tillett’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Tillett's role in Race Oncology Ltd.?
Daniel Tillett's role in Race Oncology Ltd. is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.